Fact CheckerSign in

NCT07182643Not yet recruiting

Biomarkers in the Endometrial Fluid, Tissue, and Follicular Fluid of Moderate/Severe Endometriosis Patients

An Exploratory Study of Biomarkers in the Endometrial Fluid, Tissue, and Follicular Fluid of Moderate/Severe Endometriosis Patients: a Prospective Study

Source: ClinicalTrials.gov · Last updated 19 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This study aims to explore biomarkers in the endometrial fluid and tissue of women with moderate to severe endometriosis, with a specific focus on those involved in pre-receptive endometrium and embryo implantation. This research has the potential to uncover diagnostic indicators of impaired pre-receptive endometrium, examine pathophysiological pathways, and identify future targets for therapeutic intervention. Ultimately, the findings may contribute to more personalized fertility treatments, offering new hope for women struggling with endometriosis-related infertility.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
90 (estimated)
First submitted
9 Sept 2025
Start date
1 Oct 2025
Primary completion date
31 Dec 2027
Lead sponsor
Region Stockholm
NCT number
NCT07182643

What you commit to

  • Study type: Observational
  • Planned participants: 90
  • From 1 Oct 2025 to the primary completion date, 31 Dec 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Major abdominal or pelvic surgery in the last 3 months

Other illness

  • Pelvic inflammatory disease, endometritis, STD
  • Gynaecological cancers or other malignancies in the patient's history
  • A specific genetic disease that is diagnosed before PGT in women undergoing treatment

Other

  • Pregnancy or lactation in the last 3 months
  • Uterine anomalies
  • Smoking (more than 10 cigarettes per day) or alcohol abuse
  • Immunosuppressing medicines

Who the study is looking for

  • Age 18-40 years old
  • Diagnosed with moderate/severe endometriosis by ultrasound or laparoscopy (patient group)
  • Regular menstrual cycles 28-35 days
  • Speak English or Swedish and agree to participate in the study

Age in the registry: 18 years to 40 years · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Karolinska Institute and Karolinska University Hospital Huddinge
Coordinator of this site? Confirm its status
StockholmSwedenUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.